“These findings highlight the potential of self-complementary AAVs to reduce dose requirements, minimize toxicity, and broaden clinical use of inner-ear therapies,” said the head researcher.|  Read More  JPost.com – The Jerusalem Post – All News from the Middle East, Israel, and the Jewish World  | Read More in Virtual Jerusalem   | Read More Israel Insider | NOWlej